Insmed, Inc. (INSM)
149.33
-0.67
(-0.45%)
USD |
NASDAQ |
Feb 27, 16:00
149.76
+0.43
(+0.29%)
After-Hours: 20:00
Insmed Research and Development Expense (TTM) : 771.09M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 1.320B |
| Biogen, Inc. | 1.498B |
| Madrigal Pharmaceuticals, Inc. | 387.02M |
| ACADIA Pharmaceuticals, Inc. | 328.80M |
| CorMedix, Inc. | 12.46M |